Rechallenge with bevacizumab in patients with glioblastoma progressing off therapy.

Abstract excerpt

Rechallenge with temozolomide has been shown to be a valid option in selected patients with progressive glioblastoma. Herein, we assessed the efficacy of rechallenge with bevacizumab in glioblastoma patients progressing off therapy. We retrospectively identified and analyzed the characteristics of patients with glioblastoma rechallenged with a bevacizumab-based chemotherapy regimen after having received...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Antineoplastic Agents, Immunological
• Share to Bevacizumab